Duality Advisers, LP Global Blood Therapeutics, Inc. Transaction History

Duality Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$24.9 - $40.26 $1.69 Million - $2.73 Million	-67,810 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$25.48 - $37.34 $408,979 - $599,344	16,051 Added 31.01%	67,810 $1.73 Million
Q2 2021 Aug 09, 2021	BUY	$32.46 - $43.42 $1.68 Million - $2.25 Million	51,759 New	51,759 $1.81 Million
Q4 2020 Feb 09, 2021	SELL	$37.65 - $63.77 $2.7 Million - $4.57 Million	-71,610 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $3.78 Million - $5.33 Million	71,610 New	71,610 $3.95 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.